NCT05018312

Brief Summary

The present study wish to compare the preliminarily effects and feasibility of Modified Collaborative Assessment (MCA) - a novel therapeutic approach to diagnostic assessment - with assessment-as-usual among patients with evasiveness as a core psychopathological feature in a randomised controlled study design.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
42

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Sep 2021

Typical duration for not_applicable

Geographic Reach
1 country

2 active sites

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

July 29, 2021

Completed
26 days until next milestone

First Posted

Study publicly available on registry

August 24, 2021

Completed
8 days until next milestone

Study Start

First participant enrolled

September 1, 2021

Completed
1.5 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

February 28, 2023

Completed
10 months until next milestone

Study Completion

Last participant's last visit for all outcomes

December 30, 2023

Completed
Last Updated

March 28, 2023

Status Verified

March 1, 2023

Enrollment Period

1.5 years

First QC Date

July 29, 2021

Last Update Submit

March 27, 2023

Conditions

Keywords

Therapeutic AssessmentPsychiatryPerson-centeredMental Health ServicePre-therapyCollaborative Assessment

Outcome Measures

Primary Outcomes (1)

  • University of Rhode Island Change Assessment Scale (URICA)

    The URICA is a 32-item self-report measure that includes 4 subscales measuring the motivation for change: Precontemplation, Contemplation, Action, and Maintenance. The minimum score is 32 and maximum value is 160. A higher score indicate that the patient is more ready to making changes in their life, compared to a lower.

    Baseline T0 (Week 1 after allocation) and T1 (end of intervention, an average of four weeks after allocation)

Secondary Outcomes (1)

  • Liebowitz Social Anxiety Scale-Self- Report (LSAS)

    Baseline T0 (Week 1 after allocation); T1 (end of intervention, an average of four weeks after allocation) and T2 (after one month psychotherapy)

Other Outcomes (7)

  • Rosenberg Self-Esteem Scale (RSES)

    Baseline T0 (Week 1 after allocation); T1 (end of intervention, an average of four weeks after allocation) and T2 (after one month psychotherapy)

  • General Self-Efficacy Scale (GSES)

    Baseline T0 (Week 1 after allocation); T1 (end of intervention, an average of four weeks after allocation) and T2 (after one month psychotherapy)

  • Working Alliance Inventory (WAI)

    T1 (end of intervention, an average of four weeks after allocation) and T2 (after one month psychotherapy)

  • +4 more other outcomes

Study Arms (2)

Modified Collaborative Assessment (MCA)

EXPERIMENTAL

The patients allocated to this arm will receive assessment inspired by therapeutic/collaborative assessment, as a pre-treatment to the standard psychotherapeutic treatment they will receive in the clinic.

Behavioral: Modified Collaborative Assessment (MCA)

Assessment as usual (AAU)

ACTIVE COMPARATOR

The patients allocated to this arm will receive standard assessment offered in the clinic, before proceeding to the standard psychotherapeutic treatment they will receive in the clinic.

Behavioral: Assessment as Usual (AAU)

Interventions

The Modified Collaborative Assessment (MCA) will be assessment of the patients that Is more thoroughly-done, and which will be inspired by the school of Therapeutic Assessment and Collaborative Assessment. It will include the EASE, SCID-interview, PSE, ADOS and SCIP-interviews.

Modified Collaborative Assessment (MCA)

Assessment as usual is the standard assessment the patients will receive in the clinic. It includes one or more interviews with a mental health professional in the clinic.

Assessment as usual (AAU)

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • A tentative ICD-10 diagnosis of either SAD or EPD
  • Going to be offered treatment in the psychiatric community clinics in Naestved, Maribo or Slagelse

You may not qualify if:

  • Severe physical health problems.
  • Lack of spoken and written danish corresponding to 9th grade primary school.
  • Eating disorder with BMI \< 18
  • Psychotic illness
  • Active diagnosis of substance abuse

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (2)

Psykiatrisk Klinik Maribo

Maribo, Region Sjælland, 4930, Denmark

Location

Psykiatrisk Klinik Næstved

Næstved, Region Sjælland, 4700, Denmark

Location

Related Publications (1)

  • Hovmand OR, Reinholt N, Dichmann K, Borisov R, Hjorthoj C, Arnfred S. Results of a randomized controlled superiority trial of the effect of modified collaborative assessment vs. standard assessment on patients' readiness for psychotherapy (CO-ASSM-RCT). Trials. 2024 Oct 25;25(1):716. doi: 10.1186/s13063-024-08517-8.

MeSH Terms

Conditions

Phobia, SocialPersonality Disorders

Interventions

Restraint, Physical

Condition Hierarchy (Ancestors)

Phobic DisordersAnxiety DisordersMental Disorders

Intervention Hierarchy (Ancestors)

Behavior ControlTherapeuticsImmobilizationInvestigative Techniques

Study Officials

  • Sidse Arnfred, MD PhD DMSc

    Research Unit for Psychotherapy and Psychopathology, Psychiatry West, Region Zealand MHS

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Masking Details
Masking will be applied in the data analysis process
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: Naturalistic, superiority trial
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professor, senior consultant, MD MSc PHD DMSC

Study Record Dates

First Submitted

July 29, 2021

First Posted

August 24, 2021

Study Start

September 1, 2021

Primary Completion

February 28, 2023

Study Completion

December 30, 2023

Last Updated

March 28, 2023

Record last verified: 2023-03

Data Sharing

IPD Sharing
Will not share

Locations